These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4602938)

  • 1. Letter: Treatment of vulval candidiasis with 5-fluorocytosine.
    Seligman SA
    Br Med J; 1974 Jul; 3(5924):173-4. PubMed ID: 4602938
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Treatment of vulval candidiasis with 5-fluorocytosine.
    Holt RJ
    Br Med J; 1974 Aug; 3(5929):523. PubMed ID: 4414454
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term topical treatment of vulvovaginal candidiasis with the combination of 5-fluorocytosine and candicidin.
    Kivinen S; Tarkkila T; Laakso L; Laakso K
    Curr Med Res Opin; 1979; 6(2):88-92. PubMed ID: 467093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis.
    Phillips I; Eykyn S; MacGregor GA; Jones NF
    Clin Nephrol; 1973; 1(4):271-2. PubMed ID: 4593451
    [No Abstract]   [Full Text] [Related]  

  • 5. Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine.
    Schönebeck J; Segerbrand E
    Br Med J; 1973 Nov; 4(5888):337-8. PubMed ID: 4202261
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary candidiasis treated with 5-fluorocytosine.
    Kohlschütter A; Pelet B
    Arch Dis Child; 1974 Feb; 49(2):154-6. PubMed ID: 4593821
    [No Abstract]   [Full Text] [Related]  

  • 7. Flucytosine in urinary candida infections.
    Wise GJ; Wainstein S; Goldberg P; Kozinn PJ
    Urology; 1974 Jun; 3(6):708-11. PubMed ID: 4600251
    [No Abstract]   [Full Text] [Related]  

  • 8. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 5-fluorocytosine in systemic candidiasis in infancy.
    Isacson M; Noah Z; Faber J; Herishano Y; Gottfried L
    Arch Dis Child; 1972 Dec; 47(256):954-9. PubMed ID: 4630479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S; Shaw BD; Bryant T; Donta ST
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of disseminated candidiasis with 5-fluorocytosine.
    Eilard T; Alestig K; Wahlén P
    J Infect Dis; 1974 Aug; 130(2):155-9. PubMed ID: 4842336
    [No Abstract]   [Full Text] [Related]  

  • 12. Candida albicans arthritis treated with flucytosine.
    Lindström FD; Lindholm T
    Ann Intern Med; 1973 Jul; 79(1):131. PubMed ID: 4578636
    [No Abstract]   [Full Text] [Related]  

  • 13. Endogenous Candida oculomycosis. Report of two patients treated with flucytosine.
    Robertson DM; Riley FC; Hermans PE
    Arch Ophthalmol; 1974 Jan; 91(1):33-8. PubMed ID: 4587195
    [No Abstract]   [Full Text] [Related]  

  • 14. A case series of the management of symptomatic azole-resistant candida.
    Challenor R; Pinsent S; Ekanayaka R
    Int J STD AIDS; 2012 May; 23(5):375-6. PubMed ID: 22648899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on classification and treatment of vulvovaginal candidiasis].
    Fan SR; Liu XP; Li JW; Xu AP; Liu M
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):532-5. PubMed ID: 16202291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment of cutaneous candidiasis with 5-fluorocytosine compared with nystatin.
    Gisslén H; Hersle K; Mobacken H
    Dermatologica; 1974; 148(6):362-5. PubMed ID: 4607694
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.
    Titsworth E; Grunberg E
    Antimicrob Agents Chemother; 1973 Sep; 4(3):306-8. PubMed ID: 4586144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5 fluorocytosine in the treatment of candidiasis with acute kidney failure].
    Kleinknecht D; Babinet P; Ganeval D; Schortgen E; Drouhet E
    J Urol Nephrol (Paris); 1973 Oct; 79(9):753-5. PubMed ID: 4794121
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of generalized candidiasis with 5-fluorocytosine].
    Alonso H; Aletti R; Gentiletti A
    Medicina (B Aires); 1972; 32(1):51-2. PubMed ID: 5019637
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of vaginal candidiasis with 5-fluorocytosine].
    Rubio-Lotvin B; González Ansorena R; Bolio Arista R; Ruiz Moreno JA
    Ginecol Obstet Mex; 1975 Jan; 37(219):23-5. PubMed ID: 1120598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.